Hin Chu

31.0k total citations · 5 hit papers
126 papers, 9.2k citations indexed

About

Hin Chu is a scholar working on Infectious Diseases, Epidemiology and Immunology. According to data from OpenAlex, Hin Chu has authored 126 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Infectious Diseases, 47 papers in Epidemiology and 35 papers in Immunology. Recurrent topics in Hin Chu's work include SARS-CoV-2 and COVID-19 Research (48 papers), Influenza Virus Research Studies (26 papers) and COVID-19 Clinical Research Studies (25 papers). Hin Chu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (48 papers), Influenza Virus Research Studies (26 papers) and COVID-19 Clinical Research Studies (25 papers). Hin Chu collaborates with scholars based in Hong Kong, China and United States. Hin Chu's co-authors include Jasper Fuk‐Woo Chan, Kwok‐Yung Yuen, Kelvin Kai‐Wang To, Shuofeng Yuan, Kin‐Hang Kok, Zheng Zhu, Jie Zhou, Jian‐Piao Cai, Cun Li and Andrew Chak-Yiu Lee and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Hin Chu

125 papers receiving 9.1k citations

Hit Papers

Genomic characterization of the 2019 no... 2013 2026 2017 2021 2020 2015 2022 2020 2013 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hin Chu Hong Kong 41 6.3k 1.8k 1.4k 1.3k 1.2k 126 9.2k
Peng Zhou China 42 6.3k 1.0× 1.6k 0.9× 1.6k 1.1× 1.1k 0.9× 1.0k 0.9× 172 10.4k
Jincun Zhao China 38 5.9k 0.9× 1.4k 0.8× 883 0.6× 1.6k 1.2× 1.4k 1.2× 138 7.9k
Matthew B. Frieman United States 55 7.0k 1.1× 2.4k 1.3× 1.2k 0.9× 1.8k 1.3× 906 0.8× 112 10.1k
Jian Shang China 19 7.5k 1.2× 2.1k 1.2× 707 0.5× 863 0.7× 1.5k 1.2× 58 9.7k
Shuofeng Yuan Hong Kong 33 4.4k 0.7× 1.4k 0.8× 982 0.7× 709 0.5× 797 0.7× 111 6.7k
Benjamin W. Neuman United States 32 6.2k 1.0× 2.0k 1.1× 659 0.5× 823 0.6× 874 0.7× 70 9.1k
Yushun Wan China 18 6.9k 1.1× 2.2k 1.2× 714 0.5× 834 0.6× 1.4k 1.2× 30 9.3k
Alexander L. Greninger United States 49 6.1k 1.0× 2.1k 1.2× 2.7k 1.9× 515 0.4× 1.1k 0.9× 277 10.6k
Lu Lu China 51 6.6k 1.1× 3.1k 1.7× 1.6k 1.2× 1.9k 1.4× 556 0.5× 305 11.8k
Timothy P. Sheahan United States 37 5.9k 0.9× 1.4k 0.8× 1.1k 0.8× 925 0.7× 1.2k 1.0× 84 8.0k

Countries citing papers authored by Hin Chu

Since Specialization
Citations

This map shows the geographic impact of Hin Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hin Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hin Chu more than expected).

Fields of papers citing papers by Hin Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hin Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hin Chu. The network helps show where Hin Chu may publish in the future.

Co-authorship network of co-authors of Hin Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Hin Chu. A scholar is included among the top collaborators of Hin Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hin Chu. Hin Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Na, Yanxia Chen, Can Li, et al.. (2025). Reverse genetics-derived cattle H5N1 virus from Clade 2.3.4.4b shows enhanced systemic infectivity and pathogenicity than an older Clade 1 H5N1 virus in BALB/c mice. Emerging Microbes & Infections. 14(1). 2475836–2475836. 2 indexed citations
2.
Zhou, Runhong, Yufei Mo, Jie Dai, et al.. (2025). BRD9 functions as an HIV-1 latency regulatory factor. Proceedings of the National Academy of Sciences. 122(21). e2418467122–e2418467122. 1 indexed citations
3.
Chan, Jasper Fuk‐Woo, Shuofeng Yuan, Hin Chu, Siddharth Sridhar, & Kwok‐Yung Yuen. (2024). COVID-19 drug discovery and treatment options. Nature Reviews Microbiology. 22(7). 391–407. 33 indexed citations
4.
Yuan, Shuofeng, Fan Xiao, Hongyan Li, et al.. (2023). Metal-coding assisted serological multi-omics profiling deciphers the role of selenium in COVID-19 immunity. Chemical Science. 14(38). 10570–10579. 9 indexed citations
6.
Iketani, Sho, Lihong Liu, Yicheng Guo, et al.. (2022). Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 604(7906). 553–556. 478 indexed citations breakdown →
7.
Qiao, Wei, Vincent Kwok‐Man Poon, Chris Chung‐Sing Chan, et al.. (2022). SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamsters. Nature Communications. 13(1). 44 indexed citations
8.
Deng, Jian, Bao‐Zhong Zhang, Hin Chu, et al.. (2021). Adenosine synthase A contributes to recurrent Staphylococcus aureus infection by dampening protective immunity. EBioMedicine. 70. 103505–103505. 13 indexed citations
9.
Zhang, Jinxia, Andrew Chak-Yiu Lee, Hin Chu, et al.. (2020). SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters.. Clinical Infectious Diseases. 18 indexed citations
10.
Zhou, Jie, Cun Li, Xiaojuan Liu, et al.. (2020). Infection of bat and human intestinal organoids by SARS-CoV-2. Nature Medicine. 26(7). 1077–1083. 401 indexed citations
11.
Lu, Lu, Carol Ho-Yan Fong, Jinxia Zhang, et al.. (2020). Repurposing of Miltefosine as an Adjuvant for Influenza Vaccine. Vaccines. 8(4). 754–754. 5 indexed citations
12.
Yuen, Chun‐Kit, et al.. (2020). Suppression of SARS‐CoV‐2 infection in ex‐vivo human lung tissues by targeting class III phosphoinositide 3‐kinase. Journal of Medical Virology. 93(4). 2076–2083. 40 indexed citations
13.
Yuan, Shuofeng, Hin Chu, Jingjing Huang, et al.. (2020). Viruses harness YxxØ motif to interact with host AP2M1 for replication: A vulnerable broad-spectrum antiviral target. Science Advances. 6(35). eaba7910–eaba7910. 41 indexed citations
14.
Chan, Jasper Fuk‐Woo, Kin‐Hang Kok, Zheng Zhu, et al.. (2020). Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes & Infections. 9(1). 221–236. 2117 indexed citations breakdown →
15.
Zhu, Zheng, Hin Chu, Lei Wen, et al.. (2019). Targeting SUMO Modification of the Non-Structural Protein 5 of Zika Virus as a Host-Targeting Antiviral Strategy. International Journal of Molecular Sciences. 20(2). 392–392. 23 indexed citations
16.
Lee, Andrew Chak-Yiu, Jinxia Zhang, Hin Chu, et al.. (2019). H7N9 influenza A virus activation of necroptosis in human monocytes links innate and adaptive immune responses. Cell Death and Disease. 10(6). 442–442. 23 indexed citations
17.
Zhao, Hanjun, Kelvin Kai‐Wang To, Hin Chu, et al.. (2018). Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza. Nature Communications. 9(1). 2358–2358. 38 indexed citations
18.
Zhang, Xiaomin, Qiwei Zhang, Hao Wu, et al.. (2016). Novel Mutations L228I and Y232H Cause Nonnucleoside Reverse Transcriptase Inhibitor Resistance in Combinational Pattern. AIDS Research and Human Retroviruses. 32(9). 909–917. 4 indexed citations
19.
Chu, Hin, Jinxia Zhang, Kong‐Hung Sze, et al.. (2016). Hemagglutinin of influenza A virus binds specifically to cell surface nucleolin and plays a role in virus internalization. Virology. 494. 78–88. 55 indexed citations
20.
Chu, Hin, Jie Zhou, Bosco Ho‐Yin Wong, et al.. (2014). Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology. 454-455. 197–205. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026